Atlas Trials

Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus

Clinical trial NCT06965244 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06965244
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Cutaneous Lupus Erythematosus (CLE)
Start date
2025-10-01
Primary completion
2029-02-01
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.